- Report
- January 2025
- 175 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- January 2025
- 175 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- April 2023
- 501 Pages
Global
From €4376EUR$5,000USD£3,804GBP
- Report
- April 2023
- 200 Pages
Global
From €4376EUR$5,000USD£3,804GBP
- Report
- February 2023
- 175 Pages
Global
From €4376EUR$5,000USD£3,804GBP
- Report
- July 2024
- 100 Pages
Global
From €3282EUR$3,750USD£2,853GBP
- Report
- July 2024
- 150 Pages
Global
From €3282EUR$3,750USD£2,853GBP
- Report
- July 2024
- 100 Pages
Global
From €3282EUR$3,750USD£2,853GBP
- Report
- July 2024
- 100 Pages
Global
From €3282EUR$3,750USD£2,853GBP
- Report
- June 2024
- 200 Pages
Global
From €6958EUR$7,950USD£6,048GBP
- Report
- June 2024
- 200 Pages
Global
From €6958EUR$7,950USD£6,048GBP
- Report
- April 2024
- 143 Pages
Global
From €6958EUR$7,950USD£6,048GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1094EUR$1,250USD£951GBP
- Report
- March 2024
- 174 Pages
Global
From €6564EUR$7,500USD£5,706GBP
- Report
- February 2024
- 200 Pages
Global
From €6564EUR$7,500USD£5,706GBP
- Report
- November 2023
- 30 Pages
Global
From €2844EUR$3,250USD£2,473GBP
- Report
- April 2023
- 500 Pages
Global
From €2844EUR$3,250USD£2,473GBP
- Report
- April 2023
- 200 Pages
Global
From €3457EUR$3,950USD£3,005GBP
- Report
- April 2023
- 350 Pages
Global
From €2844EUR$3,250USD£2,473GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2844EUR$3,250USD£2,473GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more